Funding for this research was provided by:
American Cancer Society (RSG-22-093-01-CCB)
Cancer Prevention and Research Institute of Texas (RR200009)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R37CA269783-01A1, T32CA203690)
National Science Foundation (2140736)
Baylor Research Advocates for Student Scholars (BRASS). Myra Branum Wilson Scholar.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 22 May 2024
Revised: 30 July 2024
Accepted: 1 August 2024
First Online: 14 August 2024
Competing interests
: GVE receives sponsored research funding from Chimerix, Inc and receives experimental mitochondria-targeting compounds from the Lead Discovery Center of Germany.